13D/13G Filings - Mirum Pharmaceuticals Inc. (MIRM)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2020-12-22
4:01 pm
Unchanged
2020-12-17 13D Mirum Pharmaceuticals, Inc.
MIRM
RiverVest Venture Fund IV L.P. 1,921,118
6.600%
0
(Unchanged)
Filing
History
2020-12-18
4:31 pm
Unchanged
2020-12-15 13D Mirum Pharmaceuticals, Inc.
MIRM
Novo Holdings A/S 2,445,147
8.400%
0
(Unchanged)
Filing
History
2020-12-18
12:40 pm
Unchanged
2020-12-17 13D Mirum Pharmaceuticals, Inc.
MIRM
Frazier Life Sciences IX L.P. 3,566,912
12.200%
0
(Unchanged)
Filing
History
Goto Prev, 0, 1, 2